Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Snezana Milanovic, MD, MSc
Sunovion Pharmaceuticals Inc., Marlborough, Massachusetts
JCP
Original Research
Fiscal Impact of Schizophrenia From a Government Perspective
August 9, 2023
This analysis revealed that the lifetime fiscal loss to the government was $1,540,042 for each person with schizophrenia.
Rui Martins
,
Aditi Kadakia
,
G. Rhys Williams
, et al